Epidermal growth factor receptor (EGFR) amplification status of isocitrate dehydrogenase-wildtype (IDHwt) lower-grade gliomas (LGGs; grade II/III) is one of the key molecular markers for diagnosing molecular glioblastoma. Our study shows that infiltrative or mixed pattern, lower ADC, lower 5th percentile of ADC, and higher 95th percentile of nCBF may be useful imaging biomarkers for the EGFR amplification of IDHwt LGGs. Moreover, quantitative imaging biomarkers may add value to qualitative imaging parameters (with AUCs of 0.71 and 0.88, p = 0.020).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords